For research use only. Not for therapeutic Use.
UCM1014（Cat No.:I037786）is an experimental compound studied for its potential in treating neurological disorders, particularly those related to oxidative stress and neurodegeneration. It is believed to exert its effects through the modulation of specific signaling pathways, possibly involving antioxidant activity or mitochondrial protection. UCM1014 has been explored in preclinical studies for its ability to reduce neuronal damage and inflammation, offering potential therapeutic benefits in conditions such as Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions. Ongoing research aims to evaluate its safety, efficacy, and therapeutic potential in clinical trials.
| Catalog Number | I037786 |
| Synonyms | UCM1014, UCM-1014, UCM 1014 |
| Molecular Formula | C21H26N2O2 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | N-[(1-benzyl-5-methoxy-3,4-dihydro-2H-quinolin-2-yl)methyl]propanamide |
| InChI | InChI=1S/C21H26N2O2/c1-3-21(24)22-14-17-12-13-18-19(10-7-11-20(18)25-2)23(17)15-16-8-5-4-6-9-16/h4-11,17H,3,12-15H2,1-2H3,(H,22,24) |
| InChIKey | VLPGTHUDTCBGRU-UHFFFAOYSA-N |
| SMILES | CCC(=O)NCC1CCC2=C(N1CC3=CC=CC=C3)C=CC=C2OC |
